Noven Pharmaceuticals, Inc

Products

Full Paper

Full Paper

Price: £95.00
Description: The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.



Research Report Overview

Published Date: 16/02/2012
Category: Emerging Technologies & Scientific Research

Research Report Decription

Noven Pharmaceuticals (Noven) is an indirect wholly-owned subsidiary of Hisamitsu Pharmaceutical. Noven is a specialty pharmaceutical engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products in the areas of women's health and psychiatric disorders. The company, through its strategic alliances, operates in the US, Europe and Japan. It is headquartered in Miami, Florida and employs more than 650 people.  Noven has not released its financial results. Therefore, data such as total revenues and operating and net profits are not available.

  • Provides all the crucial information on Noven Pharmaceuticals, Inc. required for business and competitor intelligence needs
  • Contains a study of the major internal and external factors affecting
  • Noven Pharmaceuticals, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Noven Pharmaceuticals, Inc.
  • Data is supplemented with details on Noven Pharmaceuticals, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Noven Pharmaceuticals, Inc.tant data and key trends 

Key Questions Answered:

Reasons to Purchase:

  • Support sales activities by understanding your customers’ businesses bette
  • Understand prospective partners and suppliers
  • Keep fully up to date on your competitors’ business structure, strategy and prospects
  • Obtain the most up to date company information available

Companies Mentioned:

Noven Pharmaceuticals, Inc

Paper Highlights:

Noven Pharmaceuticals (Noven) is an indirect wholly-owned subsidiary of Hisamitsu Pharmaceutical. Noven is a specialty pharmaceutical engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products in the areas of women's health and psychiatric disorders. The company, through its strategic alliances, operates in the US, Europe and Japan. It is headquartered in Miami, Florida and employs more than 650 people.  Noven has not released its financial results. Therefore, data such as total revenues and operating and net profits are not available.